MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Analyzing the metabolic function of DJ-1 in the pathogenesis of Parkinson`s disease (PD) and Glioblastoma multiforme (GBM)

    P. Mencke (Esch-sur-Alzette, Luxembourg)

    Objective: In this project, we are comprehensively studying the function of DJ-1 in PD and GBM to better understand its observed role in both, neurodegeneration…
  • 2022 International Congress

    A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease

    A. Choi, M. Delgado, K. Chen, S. Chung, A. Courville, S. Turner, S. Yang, K. Airaghi, I. Dustin, P. Mcgurrin, M. Hallett, D. Ehrlich (Sun City, USA)

    Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…
  • 2022 International Congress

    Face Name matching and memory complaints in Parkinson’s disease

    A. Siquier, P. Andrés (Palma, Spain)

    Objective: We aim to portray memory impairment in patients with Parkinson’s disease (PD) from an objective and subjective angle by using an innovative cross-modal associative…
  • 2022 International Congress

    A progress update on the Critical Path for Parkinson’s consortium’s pre-competitive 3DT initiative

    M. Müller, J. Cosman, J. Adams, R. Badawy, R. Bhatnagar, B. Bloem, C. Carroll, N. Cooray, T. Dam, D. Dexter, M. Dockendorf, R. Dorsey, M. Frasier, L. Garcia-Gancedo, D. Hill, M. Kostrzebski, E. Kunka, M. Lindemann, J. Mammen, M. Meinders, A. Mirelman, G. Roussos, S. Sardar, T. Simuni, R. Speck, G. Stebbins, K. Ward Barowicz, J. Cedarbaum, D. Stephenson (Tucson, USA)

    Objective: To provide a progress update on the Critical Path for Parkinson’s (CPP) consortium’s “Digital Drug Development” (3DT) initiative, which was established in 2019 with…
  • 2022 International Congress

    The acceptability of wearable devices to measure mobility in people with Parkinson’s Disease: observations from Mobilise-D

    A. Keogh, L. Alcock, P. Brown, M. Brozgol, E. Gazit, C. Hansen, J. Hausdorff, W. Maetzler, L. Rochester, A. Yarnall, B. Caulfield (Dublin, Ireland)

    Objective: To explore the acceptability of wearable devices to remotely measure mobility in the Mobilise-D technical validation study (TVS). Background: When deploying tools to monitor…
  • 2022 International Congress

    Classification of extremity movements by visual observation of signal transforms

    J. Brasic, L. Ziegelman, T. Kosuri, H. Hakim, L. Zhao, A. Gokce, K. Mathur, M. Hernandez, K. Mills (Baltimore, USA)

    Objective: To create a tool for raters certified in the MDS-UPDRS) [1] to blindly score online signal transforms of the output of the wearable sensors to…
  • 2022 International Congress

    Clinical Characteristics of patients with Parkinson’s disease showing normal values on SBR in the DAT SPECT

    M. Nomoto, C. Ochi, R. Ando, Y. Murakami (Imabari, Ehime, Japan)

    Objective: The aim of this study was to clarify what the ‘normal’ values of the specific binding ratio (SBR), a measure of striatal radiotracer uptake…
  • 2022 International Congress

    iFall: Usability of a co-produced falls reporting smartphone application in people with Parkinson’s

    R. Morris, J. Moore, N. Ratcliffe, G. Barry, J. Naisby, A. Amjad, A. Godfrey, G. Standerline, E. Webster (Newcastle upon Tyne, United Kingdom)

    Objective: To assess the usability of a co-produced smartphone application for falls reporting in people with Parkinson’s (PwP) Background: Falls commonly occur in PwP, which…
  • 2022 International Congress

    Long-Term Neuropsychological Outcomes of Deep Brain Stimulation in Early-Stage Parkinson’s Disease

    M. Hacker, M. Tramontana, J. Meystedt, M. Turchan, K. Harper, B. Eoff, R. Fan, F. Ye, T. Davis, P. Konrad, D. Charles (Nashville, USA)

    Objective: To report long-term (5-year and 11-year) neuropsychological outcomes from the deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot clinical trial. Background: The…
  • 2022 International Congress

    Challenges and Opportunities People with Parkinson’s Disease Experienced Pre and Post-Covid-19 Vaccination

    L. Currens, S. Carbone, J. Quast, W. Deeb (Worcester, USA)

    Objective: To determine the specific challenges and opportunities people with Parkinson’s disease (PWP) experienced before and after receiving the Covid-19 vaccine. Background: The Covid-19 pandemic…
  • « Previous Page
  • 1
  • …
  • 470
  • 471
  • 472
  • 473
  • 474
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley